In refractory germ cell tumor, in the absence of results of the randomized TIGER trial, how do you determine if patients should be treated with conventional-dose chemotherapy versus high-dose chemotherapy?  

What factors do you consider to aid in this decision making? The TIGER trial is a prospective randomized trial comparing these approaches.



Answer from: Medical Oncologist at Community Practice